Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AbbVie Inc.ABBV · Entity 2800 | Director | September 30, 2026 | October 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AbbVie Inc.
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $261.59 | Direct | 918 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 59 · Balance 918 F1: Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. |
Filing footnotes · ownership attribution and instrument terms
F1: Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 01:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 59 | $261.59 Strike: $261.59 | $15,433.81 |
DisclosureSEC source: 0001997505-26-000010 · form4-10022026_051005.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 918 Underlying: Common Stock · 59 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 62 | $251.64 Strike: $251.64 | $15,601.68 |
DisclosureSEC source: 0001997505-26-000008 · form4-07022026_050702.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 853 Underlying: Common Stock · 62 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 08, 2026 Filed May 12, 2026 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001997505-26-000006 · form4-05122026_050515.xml · nonDerivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,643 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 71 | $217.49 Strike: $217.49 | $15,441.79 |
DisclosureSEC source: 0001997505-26-000004 · form4-04022026_050411.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 784 Underlying: Common Stock · 71 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 22:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 68 | $228.49 Strike: $228.49 | $15,537.32 |
DisclosureSEC source: 0001997505-26-000002 · form4-01052026_050108.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 707 Underlying: Common Stock · 68 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 67 | $231.54 Strike: $231.54 | $15,513.18 |
DisclosureSEC source: 0001997505-25-000005 · form4-10022025_051001.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 634 Underlying: Common Stock · 67 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2025 Filed Jul 2, 2025 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 81 | $185.62 Strike: $185.62 | $15,035.22 |
DisclosureSEC source: 0001415889-25-019105 · form4-07022025_050701.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 562 Underlying: Common Stock · 81 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 09, 2025 Filed May 13, 2025 21:05 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-012799 · form4-05132025_050515.xml · nonDerivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,525 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 71 | $209.52 Strike: $209.52 | $14,875.92 |
DisclosureSEC source: 0001415889-25-009689 · form4-04022025_050407.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 476 Underlying: Common Stock · 71 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2024 Filed Jan 3, 2025 22:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 84 | $177.70 Strike: $177.70 | $14,926.80 |
DisclosureSEC source: 0001415889-25-000519 · form4-01032025_050103.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 401 Underlying: Common Stock · 84 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 75 | $197.48 Strike: $197.48 | $14,811.00 |
DisclosureSEC source: 0001415889-24-024450 · form4-10022024_051002.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314 Underlying: Common Stock · 75 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 20:20 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 87 | $171.52 Strike: $171.52 | $14,922.24 |
DisclosureSEC source: 0000897069-24-001475 · form4.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 236 Underlying: Common Stock · 87 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| May 03, 2024 Filed May 7, 2024 22:31 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantCommon Stock, $0.01 par value | 1,322 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-012530 · form4-05072024_100540.xml · nonDerivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,322 F1 · shares: These are restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program (the "Program"). They will be paid, on a one-to-one basis, in shares of AbbVie common stock on the earlier of the date of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program). Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 21:00 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 82 | $182.10 Strike: $182.10 | $14,932.20 |
DisclosureSEC source: 0001415889-24-009800 · form4-04022024_050401.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147 Underlying: Common Stock · 82 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F2 · balance_after: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:17 UTC | AbbVie Inc. ABBV · Entity 2800 | GrantStock Equivalent Units · Derivative | 64 | $154.97 Strike: $154.97 | $9,918.08 |
DisclosureSEC source: 0001415889-24-000345 · form4-01032024_100158.xml · derivative · entry 1 Quaggin Susan E · CIK 0001997505 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64 Underlying: Common Stock · 64 shares Expires not disclosed F1 · derivative.exercise_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. F1 · derivative.expiration_date: Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in AbbVie stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.